Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections

Ophthalmology

Volumn 117, Issue 11, 2010, Pages 2141-2145

  Moss, Jason M ^a   Sanislo, Steven R ^a   Ta, Christopher N ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; METICILLIN; MOXIFLOXACIN; OXACILLIN; PENICILLIN G; TETRACYCLINE; VANCOMYCIN; ANGIOGENESIS INHIBITOR; ANTIINFECTIVE AGENT; GLUCOCORTICOID;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL FLORA; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL EVALUATION; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONJUNCTIVA; CONTROLLED STUDY; DISK DIFFUSION; FEMALE; GRAM NEGATIVE AEROBIC RODS AND COCCI; HUMAN; INJECTION SITE; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; MICROCOCCUS; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; BACTERIA; DRUG EFFECTS; INJECTION; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; VERY ELDERLY; VITREOUS BODY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTI-BACTERIAL AGENTS; BACTERIA; CONJUNCTIVA; DRUG RESISTANCE, BACTERIAL; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; VITREOUS BODY;

EID: 78049251745     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.02.030     Document Type: Article

References (35)

1. R.J. Antcliff, D.J. Spalton, and M.R. Stanford Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study Ophthalmology 108 2001 765 772
2. P.B. Greenberg, A. Martidis, and A.H. Rogers Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion [letter] Br J Ophthalmol 86 2002 247 248
3. A. Martidis, J.S. Duker, and C.A. Puliafito Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy Arch Ophthalmol 119 2001 1380 1383
4. I.U. Scott, H.W. Flynn Jr, and P.J. Rosenfeld Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema Am J Ophthalmol 136 2003 737 739
5. S. Young, G. Larkin, M. Branley, and S. Lightman Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis Clin Experiment Ophthalmol 29 2001 2 6
6. R. Jorge, R.A. Costa, and D. Calucci Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE Study) Retina 26 2006 1006 1013
7. Macugen Diabetic Retinopathy Study Group A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema Ophthalmology 112 2005 1747 1757
8. E.S. Gragoudas, A.P. Adamis, E.T. Cunningham Jr VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group Pegaptanib for neovascular age-related macular degeneration N Engl J Med 351 2004 2805 2816
9. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
10. P. Yoganathan, V.A. Deramo, and J.C. Lai Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration Retina 26 2006 994 998
11. R.D. Jager, L.P. Aiello, S.C. Patel, and E.T. Cunningham Jr Risks of intravitreous injection: a comprehensive review Retina 24 2004 676 698
12. J.J. de Caro, C.N. Ta, and H.K. Ho Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections Retina 28 2008 877 883
13. I.U. Scott, and H.W. Flynn Jr The role of topical antibiotic prophylaxis for intravitreal injections Arch Ophthalmol 125 2007 974 976
14. C.N. Ta Topical antibiotic prophylaxis in intraocular injections Arch Ophthalmol 125 2007 972 974
15. J.M. Moss, S.R. Sanislo, and C.N. Ta A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections Ophthalmology 116 2009 1498 1501
16. O. Artunay, E. Yuzbasioglu, and R. Rasier Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection Eye (Lond) 23 2009 2187 2193
17. D.R. Fintak, G.K. Shah, and K.J. Blinder Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab Retina 28 2008 1395 1399
18. J.O. Mason III, M.F. White, and R.M. Feist Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection Retina 28 2008 564 567
19. H.S. Alkuraya, A.S. Al-Kharashi, E. Alharthi, and I.A. Chaudhry Acute endophthalmitis caused by Staphylococcus lugdunesis after intravitreal bevacizumab (Avastin) injection Int Ophthalmol 29 2009 411 413
20. J.F. John, and A.M. Harvin History and evolution of antibiotic resistance in coagulase-negative staphylococci: susceptibility profiles of new anti-staphylococcal agents Ther Clin Risk Manag 3 2007 1143 1152
21. A. Pinna, S. Zanetti, and M. Sotgiu Identification and antibiotic susceptibility of coagulase negative staphylococci isolated in corneal/external infections Br J Ophthalmol 83 1999 771 773
22. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
23. J.S. Heier, A.N. Antoskyk, and P.R. Pavan Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study Ophthalmology 113 2006 633 642
24. P.J. Rosenfeld, R.M. Rich, and G.A. Lalwani Ranibizumab: phase III clinical trial results Ophthalmol Clin North Am 19 2006 361 372
25. S. Pilli, A. Kotsolis, and J. Slakter Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting Am J Ophthalmol 145 2008 879 882
26. T. Diago, C.A. McCannel, and S.J. Bakri Infectious endophthalmitis after intravitreal injection of antiangiogenic agents Retina 29 2009 601 605
27. A.R. Bhavsar, J.M. Googe Jr, C.R. Stockdale Diabetic Retinopathy Clinical Research Network Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the Diabetic Retinopathy Clinical Research Network laser-ranibizumab-triamcinolone clinical trials Arch Ophthalmol 127 2009 1581 1583
28. C.N. Ta, R.T. Chang, and K. Singh Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery Ophthalmology 110 2003 1946 1951
29. C.N. Ta, L. He, and H. Mino de Kaspar In vitro antibiotic susceptibility of preoperative normal conjunctival bacteria Eye (Lond) 23 2009 559 560
30. J.L. Chung, K.Y. Seo, and D.E. Yong Antibiotic susceptibility of conjunctival bacterial isolates from refractive surgery patients Ophthalmology 116 2009 1067 1074
31. H. Mino de Kaspar, M.J. Koss, and L. He Antibiotic susceptibility of preoperative normal conjunctival bacteria Am J Ophthalmol 139 2005 730 733
32. M.J. Koss, M. Eder, and M.S. Blumenkranz The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva [in German] Ophthalmologe 104 2007 21 27
33. A.I. Saa, J. Vivas, and A. Tinajas Evaluation of the MicroScan system for identification of staphylococci J Basic Microbiol 39 1999 373 376
34. L. Del'Alamo, R.F. Cereda, and I. Tosin Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides Diagn Microbiol Infect Dis 34 1999 185 191
35. A. McGregor, F. Schio, and S. Beaton The MicroScan WalkAway diagnostic microbiology systeman evaluation Pathology 27 1995 172 176